Drug accumulation in melanin: an affinity chromatographic study

Area of Science:

• Pharmacology
• Biochemistry
• Chromatography

Background:

• Melanin, a biopolymer, interacts with various exogenous compounds, including drugs.
• Understanding drug-melanin interactions is crucial for predicting drug distribution, efficacy, and potential toxicity.
• Previous methods for assessing drug-melanin affinity were limited in characterizing complex binding behaviors.

Purpose of the Study:

• To develop and apply an affinity chromatographic method for indirectly assessing the binding affinity of drugs to immobilized melanin.
• To characterize the complex binding behaviors between drugs and melanin, including various interaction types.
• To differentiate the binding characteristics of different drugs based on their interactions with melanin.

Main Methods:

• Utilized affinity chromatography with immobilized melanin as the stationary phase.
• Applied nonlinear, exponential curve fitting to plots of drug retention versus the number of molecules applied.
• Analyzed binding behavior based on parameter estimates derived from the fitting procedure.

Main Results:

• Drug retention on the melanin affinity column exhibited nonlinear, exponential behavior, varying distinctively for each drug.
• The binding behavior was complex, involving hydrogen bonding, hydrophobic, and ionic interactions.
• Cooperative and anti-cooperative interactions between drug molecules and melanin were observed.
• The nonlinear fitting approach successfully discriminated between different drug-melanin binding profiles.

Conclusions:

• Affinity chromatography provides a valuable method for studying drug-melanin interactions.
• Drug binding to melanin is complex and involves multiple interaction types.
• The characterized binding behaviors can inform predictions of drug disposition and potential side effects related to melanin binding.